Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lopez, F; Ferjoux, G; Cordelier, P; Saint-Laurent, N; Esteve, JP; Vaysse, N; Buscail, L; Susini, C
   Neuronal nitric oxide synthase is a SHP-1 substrate involved in sst2 somatostatin receptor growth inhibitory signaling
   FASEB JOURNAL
   
   F. Lopez et al., "Neuronal nitric oxide synthase is a SHP-1 substrate involved in sst2 somatostatin receptor growth inhibitory signaling", FASEB J, 15(10), 2001, pp. NIL_4-NIL_20
2. Waysbort, A; Bonnal, S; Audigier, S; Esteve, JP; Prats, AC
   Pyrimidine tract binding protein and La autoantigen interact differently with the 5 ' untranslated regions of lentiviruses and oncoretrovirus mRNAs
   FEBS LETTERS
   
   A. Waysbort et al., "Pyrimidine tract binding protein and La autoantigen interact differently with the 5 ' untranslated regions of lentiviruses and oncoretrovirus mRNAs", FEBS LETTER, 490(1-2), 2001, pp. 54-58
3. Benali, N; Cordelier, P; Calise, D; Pages, P; Rochaix, P; Nagy, A; Esteve, JP; Pour, PM; Schally, AV; Vaysse, N; Susini, C; Buscail, L
   Inhibition of growth and metastatic progression of pancreatic carcinoma inhamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238
   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
   
   N. Benali et al., "Inhibition of growth and metastatic progression of pancreatic carcinoma inhamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238", P NAS US, 97(16), 2000, pp. 9180-9185
4. Rochaix, P; Delesque, N; Esteve, JP; Saint-Laurent, N; Voigt, JJ; Vaysse, N; Susini, C; Buscail, L
   Gene therapy for pancreatic carcinoma: Local and distant antitumor effectsafter somatostatin receptor sst2 gene transfer
   HUMAN GENE THERAPY
   
   P. Rochaix et al., "Gene therapy for pancreatic carcinoma: Local and distant antitumor effectsafter somatostatin receptor sst2 gene transfer", HUM GENE TH, 10(6), 1999, pp. 995-1008
5. Cordelier, P; Esteve, JP; Rivard, N; Marletta, M; Vaysse, N; Susini, C; Buscail, L
   The activation of neuronal NO synthase is mediated by G-protein beta gammasubunit and the tyrosine phosphatase SHP-2
   FASEB JOURNAL
   
   P. Cordelier et al., "The activation of neuronal NO synthase is mediated by G-protein beta gammasubunit and the tyrosine phosphatase SHP-2", FASEB J, 13(14), 1999, pp. 2037-2050
6. Pages, P; Benali, N; Saint-Laurent, N; Esteve, JP; Schally, AV; Tkaczuk, J; Vaysse, N; Susini, C; Buscail, L
   sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1) - Evidence for the role of SHP-1
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   P. Pages et al., "sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1) - Evidence for the role of SHP-1", J BIOL CHEM, 274(21), 1999, pp. 15186-15193
7. BOUSQUET C; DELESQUE N; LOPEZ F; SAINTLAURENT N; ESTEVE JP; BEDECS K; BUSCAIL L; VAYSSE N; SUSINI C
   SST2 SOMATOSTATIN RECEPTOR MEDIATES NEGATIVE REGULATION OF INSULIN-RECEPTOR SIGNALING THROUGH THE TYROSINE PHOSPHATASE SHP-1
   The Journal of biological chemistry
   
   C. Bousquet et al., "SST2 SOMATOSTATIN RECEPTOR MEDIATES NEGATIVE REGULATION OF INSULIN-RECEPTOR SIGNALING THROUGH THE TYROSINE PHOSPHATASE SHP-1", The Journal of biological chemistry, 273(12), 1998, pp. 7099-7106
8. ROCHAIX P; DELESQUE N; ESTEVE JP; SAINTLAURENT N; VOIGT JJ; VAYSSE N; SUSINI C; BUSCAIL L
   GENE-TRANSFER OF SST2 SOMATOSTATIN RECEPTOR - A MODEL OF GENE-THERAPYFOR PANCREATIC-CANCER
   Gastroenterology
   
   P. Rochaix et al., "GENE-TRANSFER OF SST2 SOMATOSTATIN RECEPTOR - A MODEL OF GENE-THERAPYFOR PANCREATIC-CANCER", Gastroenterology, 114(4), 1998, pp. 2757-2757
9. CORDELIER P; ESTEVE JP; ROCHAIX P; VOIGT JJ; SCHALLY AV; VAYSSE N; SUSINI C; BUSCAIL L
   ROLE OF NITRIC-OXIDE IN THE ANTIPROLIFERATIVE SIGNAL MEDIATED BY THE SOMATOSTATIN RECEPTOR SST5
   Gastroenterology
   
   P. Cordelier et al., "ROLE OF NITRIC-OXIDE IN THE ANTIPROLIFERATIVE SIGNAL MEDIATED BY THE SOMATOSTATIN RECEPTOR SST5", Gastroenterology, 114(4), 1998, pp. 4651-4651
10. LOPEZ F; FERJOUX G; SAINTLAURENT N; ESTEVE JP; VIVIER E; VELY F; BUSCAIL L; VAYSSE N; SUSINI C
    SHP2 TYROSINE PHOSPHATASE ASSOCIATES WITH SST2 SOMATOSTATIN RECEPTOR
    Gastroenterology
    
    F. Lopez et al., "SHP2 TYROSINE PHOSPHATASE ASSOCIATES WITH SST2 SOMATOSTATIN RECEPTOR", Gastroenterology, 114(4), 1998, pp. 4749-4749
11. CORDELIER P; ESTEVE JP; BOUSQUET C; DELESQUE N; OCARROLL AM; SCHALLY AV; VAYSSE N; SUSINI C; BUSCAIL L
    CHARACTERIZATION OF THE ANTIPROLIFERATIVE SIGNAL MEDIATED BY THE SOMATOSTATIN RECEPTOR SUBTYPE SST5
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    P. Cordelier et al., "CHARACTERIZATION OF THE ANTIPROLIFERATIVE SIGNAL MEDIATED BY THE SOMATOSTATIN RECEPTOR SUBTYPE SST5", Proceedings of the National Academy of Sciences of the United Statesof America, 94(17), 1997, pp. 9343-9348
12. CARON P; BUSCAIL L; BECKERS A; ESTEVE JP; IGOUT A; HENNEN G; SUSINI C
    EXPRESSION OF SOMATOSTATIN RECEPTOR SST4 IN HUMAN PLACENTA AND ABSENCE OF OCTREOTIDE EFFECT ON HUMAN PLACENTAL GROWTH-HORMONE CONCENTRATIONDURING PREGNANCY
    The Journal of clinical endocrinology and metabolism
    
    P. Caron et al., "EXPRESSION OF SOMATOSTATIN RECEPTOR SST4 IN HUMAN PLACENTA AND ABSENCE OF OCTREOTIDE EFFECT ON HUMAN PLACENTAL GROWTH-HORMONE CONCENTRATIONDURING PREGNANCY", The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3771-3776
13. LOPEZ F; ESTEVE JP; BUSCAIL L; DELESQUE N; SAINTLAURENT N; THEVENIAU M; NAHMIAS C; VAYSSE N; SUSINI C
    THE TYROSINE PHOSPHATASE SHP-1 ASSOCIATES WITH THE SST2 SOMATOSTATIN RECEPTOR AND IS AN ESSENTIAL COMPONENT OF SST2-MEDIATED INHIBITORY GROWTH SIGNALING
    The Journal of biological chemistry
    
    F. Lopez et al., "THE TYROSINE PHOSPHATASE SHP-1 ASSOCIATES WITH THE SST2 SOMATOSTATIN RECEPTOR AND IS AN ESSENTIAL COMPONENT OF SST2-MEDIATED INHIBITORY GROWTH SIGNALING", The Journal of biological chemistry, 272(39), 1997, pp. 24448-24454
14. PAGES P; BUSCAIL L; DELESQUE N; SAINTLAURENT N; ESTEVE JP; TKACZUK J; SCHALLY AV; VAYSSE N; SUSINI C
    G1 CELL-CYCLE ARREST AND UP-REGULATION OF P27(KIP1) EXPRESSION AFTER ACTIVATION OF SOMATOSTATIN SST2 RECEPTOR
    Gastroenterology
    
    P. Pages et al., "G1 CELL-CYCLE ARREST AND UP-REGULATION OF P27(KIP1) EXPRESSION AFTER ACTIVATION OF SOMATOSTATIN SST2 RECEPTOR", Gastroenterology, 112(4), 1997, pp. 635-635
15. BOUSQUET C; DELESQUE N; LOPEZ F; SAINTLAURENT N; ESTEVE JP; BUSCAIL L; VAYSSE N; SUSINI C
    SOMATOSTATIN NEGATIVELY REGULATES INSULIN SIGNALING BY STIMULATING THE TYROSINE PHOSPHATASE SHP-1 IN CELLS EXPRESSING SST2 SOMATOSTATIN RECEPTOR
    Gastroenterology
    
    C. Bousquet et al., "SOMATOSTATIN NEGATIVELY REGULATES INSULIN SIGNALING BY STIMULATING THE TYROSINE PHOSPHATASE SHP-1 IN CELLS EXPRESSING SST2 SOMATOSTATIN RECEPTOR", Gastroenterology, 112(4), 1997, pp. 1134-1134
16. DELESQUE N; BUSCAIL L; ESTEVE JP; SAINTLAURENT N; MULLER C; WECKBECKER G; BRUNS C; VAYSSE N; SUSINI C
    SST2 SOMATOSTATIN RECEPTOR EXPRESSION REVERSES TUMORIGENICITY OF HUMAN PANCREATIC-CANCER CELLS
    Cancer research
    
    N. Delesque et al., "SST2 SOMATOSTATIN RECEPTOR EXPRESSION REVERSES TUMORIGENICITY OF HUMAN PANCREATIC-CANCER CELLS", Cancer research, 57(5), 1997, pp. 956-962
17. LOPEZ F; ESTEVE JP; BUSCAIL L; DELESQUE N; SAINTLAURENT N; VAYSSE N; SUSINI C
    MOLECULAR MECHANISMS OF ANTIPROLIFERATIVE EFFECT OF SOMATOSTATIN - INVOLVEMENT OF A TYROSINE PHOSPHATASE
    Metabolism, clinical and experimental
    
    F. Lopez et al., "MOLECULAR MECHANISMS OF ANTIPROLIFERATIVE EFFECT OF SOMATOSTATIN - INVOLVEMENT OF A TYROSINE PHOSPHATASE", Metabolism, clinical and experimental, 45(8), 1996, pp. 14-16
18. RAULY I; SAINTLAURENT N; DELESQUE N; BUSCAIL L; ESTEVE JP; VAYSSE N; SUSINI C
    INDUCTION OF A NEGATIVE AUTOCRINE LOOP BY EXPRESSION OF SST2 SOMATOSTATIN RECEPTOR IN NIH 3T3 CELLS
    The Journal of clinical investigation
    
    I. Rauly et al., "INDUCTION OF A NEGATIVE AUTOCRINE LOOP BY EXPRESSION OF SST2 SOMATOSTATIN RECEPTOR IN NIH 3T3 CELLS", The Journal of clinical investigation, 97(8), 1996, pp. 1874-1883
19. DELESQUE N; BUSCAIL L; ESTEVE JP; SAINTLAURENT N; MULLER C; CAPELLA G; WECKBECKER G; BRUNS C; VAYSSE N; SUSINI C
    THE SST2 SOMATOSTATIN RECEPTOR SUBTYPE IS A TUMOR-SUPPRESSOR GENE FORHUMAN PANCREATIC-CANCER
    Gastroenterology
    
    N. Delesque et al., "THE SST2 SOMATOSTATIN RECEPTOR SUBTYPE IS A TUMOR-SUPPRESSOR GENE FORHUMAN PANCREATIC-CANCER", Gastroenterology, 110(4), 1996, pp. 507-507
20. ALVAROALONSO I; COLAS B; ESTEVE JP; SUSINI C; ARILLA E
    SOMATOSTATIN RECEPTOR-EFFECTOR SYSTEM IN RAT PANCREATIC ACINAR MEMBRANES AFTER SUBTOTAL ENTERECTOMY
    American journal of physiology: endocrinology and metabolism
    
    I. Alvaroalonso et al., "SOMATOSTATIN RECEPTOR-EFFECTOR SYSTEM IN RAT PANCREATIC ACINAR MEMBRANES AFTER SUBTOTAL ENTERECTOMY", American journal of physiology: endocrinology and metabolism, 31(2), 1995, pp. 343-348
21. BUSCAIL L; ESTEVE JP; SAINTLAURENT N; BERTRAND V; REISINE T; OCARROLL AM; BELL GI; SCHALLY AV; VAYSSE N; SUSINI C
    INHIBITION OF CELL-PROLIFERATION BY THE SOMATOSTATIN ANALOG RC-160 ISMEDIATED BY SOMATOSTATIN RECEPTOR SUBTYPES SSTR2 AND SSTR5 THROUGH DIFFERENT MECHANISMS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    L. Buscail et al., "INHIBITION OF CELL-PROLIFERATION BY THE SOMATOSTATIN ANALOG RC-160 ISMEDIATED BY SOMATOSTATIN RECEPTOR SUBTYPES SSTR2 AND SSTR5 THROUGH DIFFERENT MECHANISMS", Proceedings of the National Academy of Sciences of the United Statesof America, 92(5), 1995, pp. 1580-1584
22. BUSCAIL L; ESTEVE JP; SAINTLAURENT N; BERTRAND V; CHASTRE E; VAILLANT JC; GESPACH C; REISINE T; OCARROLL AM; KALTHOF H; BELL GI; SCHALLY AV; VAYSSE N; SUSINI C
    THE SOMATOSTATIN RECEPTOR SUBTYPE-SSTR2 AND SUBTYPE-SSTR5 MEDIATE THEINHIBITION OF CELL-PROLIFERATION
    Gastroenterology
    
    L. Buscail et al., "THE SOMATOSTATIN RECEPTOR SUBTYPE-SSTR2 AND SUBTYPE-SSTR5 MEDIATE THEINHIBITION OF CELL-PROLIFERATION", Gastroenterology, 108(4), 1995, pp. 955-955
23. DELESQUE N; RAULY I; BUSCAIL L; ESTEVE JP; BELL GI; SCHALLY AV; VAYSSE N; SUSINI C
    EXPRESSION OF SSSTR2 SOMATOSTATIN RECEPTOR SUBTYPE INHIBTED PANCREATIC TUMOR-CELL GROWTH
    Gastroenterology
    
    N. Delesque et al., "EXPRESSION OF SSSTR2 SOMATOSTATIN RECEPTOR SUBTYPE INHIBTED PANCREATIC TUMOR-CELL GROWTH", Gastroenterology, 108(4), 1995, pp. 960-960
24. ESTEVE JP; LOPEZ F; BUSCAIL L; DELESQUE N; SAINTLAURENT N; REISINE T; BELL GI; VAYSSE N; SUSINI C
    ASSOCIATION OF TYROSINE PHOSPHATASE SHPTP1 TO SSTR2 SOMATOSTATIN RECEPTOR SUBTYPE
    Gastroenterology
    
    J.P. Esteve et al., "ASSOCIATION OF TYROSINE PHOSPHATASE SHPTP1 TO SSTR2 SOMATOSTATIN RECEPTOR SUBTYPE", Gastroenterology, 108(4), 1995, pp. 964-964
25. CAMBILLAU C; RAULY I; SARFATI P; SAINTLAURENT N; ESTEVE JP; FANJUL M; SVOBODA M; PRATS H; HOLLANDE E; VAYSSE N; SUSINI C
    REGULATION OF THE SRC-HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN-TYROSINE-PHOSPHATASE PTP1C BY GLUCOCORTICOIDS IN RAT PANCREATIC AR42J CELLS
    Endocrinology
    
    C. Cambillau et al., "REGULATION OF THE SRC-HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN-TYROSINE-PHOSPHATASE PTP1C BY GLUCOCORTICOIDS IN RAT PANCREATIC AR42J CELLS", Endocrinology, 136(12), 1995, pp. 5476-5484
26. ZEGGARI M; ESTEVE JP; RAULY I; CAMBILLAU C; MAZARGUIL H; DUFRESNE M; PRADAYROL L; CHAYVIALLE JA; VAYSSE N; SUSINI C
    COPURIFICATION OF A PROTEIN-TYROSINE-PHOSPHATASE WITH ACTIVATED SOMATOSTATIN RECEPTORS FROM RAT PANCREATIC ACINAR MEMBRANES
    Biochemical journal
    
    M. Zeggari et al., "COPURIFICATION OF A PROTEIN-TYROSINE-PHOSPHATASE WITH ACTIVATED SOMATOSTATIN RECEPTORS FROM RAT PANCREATIC ACINAR MEMBRANES", Biochemical journal, 303, 1994, pp. 441-448
27. BUSCAIL L; DELESQUE N; ESTEVE JP; SAINTLAURENT N; PRATS H; CLERC P; ROBBERECHT P; BELL GI; LIEBOW C; SCHALLY AV; VAYSSE N; SUSINI C
    STIMULATION OF TYROSINE PHOSPHATASE AND INHIBITION OF CELL-PROLIFERATION BY SOMATOSTATIN ANALOGS - MEDIATION BY HUMAN SOMATOSTATIN RECEPTORSUBTYPES SSTR1 AND SSTR2
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    L. Buscail et al., "STIMULATION OF TYROSINE PHOSPHATASE AND INHIBITION OF CELL-PROLIFERATION BY SOMATOSTATIN ANALOGS - MEDIATION BY HUMAN SOMATOSTATIN RECEPTORSUBTYPES SSTR1 AND SSTR2", Proceedings of the National Academy of Sciences of the United Statesof America, 91(6), 1994, pp. 2315-2319
28. VIDAL C; RAULY I; ZEGGARI M; DELESQUE N; ESTEVE JP; SAINTLAURENT N; VAYSSE N; SUSINI C
    UP-REGULATION OF SOMATOSTATIN RECEPTORS BY EPIDERMAL GROWTH-FACTOR AND GASTRIN IN PANCREATIC-CANCER CELLS
    Molecular pharmacology
    
    C. Vidal et al., "UP-REGULATION OF SOMATOSTATIN RECEPTORS BY EPIDERMAL GROWTH-FACTOR AND GASTRIN IN PANCREATIC-CANCER CELLS", Molecular pharmacology, 46(1), 1994, pp. 97-104
29. BUSCAIL L; DELESQUE N; ESTEVE JP; SAINTLAURENT N; PRATS H; CLERC P; BELL GI; LIEBOW C; SCHALLY AV; VAYSSE N; SUSINI C
    EXPRESSION AND EFFECT ON CELL-PROLIFERATION OF THE HUMAN SSTR1 AND SSTR2 SOMATOSTATIN RECEPTOR SUBTYPES
    Gastroenterology
    
    L. Buscail et al., "EXPRESSION AND EFFECT ON CELL-PROLIFERATION OF THE HUMAN SSTR1 AND SSTR2 SOMATOSTATIN RECEPTOR SUBTYPES", Gastroenterology, 106(4), 1994, pp. 10000802-10000802
30. CAMBILLAU C; ESTEVE JP; BUSCAIL L; SUSINI C; VAYSSE N
    SOMATOSTATIN RECEPTOR IN PANCREATIC-CANCER CELLS - ROLE OF TYROSINE PHOSPHATASE IN INHIBITING RECEPTOR-MEDIATED CELL-PROLIFERATION
    International journal of pancreatology
    
    C. Cambillau et al., "SOMATOSTATIN RECEPTOR IN PANCREATIC-CANCER CELLS - ROLE OF TYROSINE PHOSPHATASE IN INHIBITING RECEPTOR-MEDIATED CELL-PROLIFERATION", International journal of pancreatology, 14(1), 1993, pp. 68-69
31. BUSCAIL L; ESTEVE JP; PRATS H; BAYARD F; BELL GI; VAYSSE N; SUSINI C
    HUMAN SOMATOSTATIN RECEPTOR HSSTR2 MAY MEDIATE THE ANTIPROLIFERATIVE EFFECT OF OCTREOTIDE
    Gastroenterology
    
    L. Buscail et al., "HUMAN SOMATOSTATIN RECEPTOR HSSTR2 MAY MEDIATE THE ANTIPROLIFERATIVE EFFECT OF OCTREOTIDE", Gastroenterology, 104(4), 1993, pp. 816-816